Best JP Orlov Podcasts (2026)

1
Why Not All Traction Is Equal | Aligning Latam’s Agtech Innovation with Industry Needs | The Role of LPs in Early VC Investing | Long-Term Thinking in Fundraising, with Galit Flasterstein, Managing Partner ... 54:46

Play Pause

9M ago54:46

54:46

Biodiversity as an Advantage Galit is a Managing Partner at Danta Fund, a VC firm that backs early-stage agritech startups in Latin America. Danta Fund has the mission of filling three main voids in Latin America: funding in early-stage agri-tech startups, mentorship to guide their founders, and connection with larger markets to help them grow. Top…

1
Unlocking Unsung Potential | LATAM Biotech’s Global Path | What Investors Really Look For | Avoiding Unforced Errors | Why Tulsa? | Building Cross-Border Deeptech Startups, with Michael Basch, GP and CEO ... 52:53

9M ago52:53

52:53

Why not Tulsa? Michael is the Founder, CEO, and General Partner of Atento Capital, a pre-seed and seed-stage VC firm focused on partnering with founders to build technology around healthcare, climate-tech, and business services. Topics in this episode 0:00 Intro 1:13 Michael’s Career Journey: From Founder to VC 4:07 The Origin Story of Atento Capit…

1
Why No Idea Is Truly Unique | Leveraging Warm Intros and Mentorships | Communicating Urgency and Opportunities to VCs | Success Beyond Funding | Inside NYU’s Acceleration Program with Khoa Ma, Associate ... 1:03:13

9M ago1:03:13

1:03:13

Are there unique ideas anymore? Khoa Ma is an Associate Director at Endless Frontier Labs, a program at NYU Stern School of Business for early-stage science and technology startups. Topics in this episode 0:00 Intro 1:07 Khoa’s Career Path 3:22 How Endless Frontier Labs Evaluates Startups 8:45 What Gets Startups Into Endless Frontier Labs 11:22 Mos…

1
Balancing Risk Across Two Industries | From Scientist to VC to Founder | Building Trust Among Co-founders | Protecting IP & Unlocking Markets | Fundraising Insights from Brazil with Larissa de Farias Viana ... 57:22

10M ago57:22

57:22

Can a single innovation unlock multiple billion-dollar markets? Larissa is the CEO of APEXzymes, a Brazilian biotech startup that produces cost-effective enzymes for sustainable industrial applications. During our conversation, Larissa shares her journey from chemical engineering to venture capital and entrepreneurship. Topics in this episode 0:00 …

1
The Business Case for Carbon Capture | A $200B Opportunity | Rethinking Industrial Supply Chains | Why You Need to Talk to Customers Early | Leveraging Non-Dilutive Capital with Alexander Ip, CEO @ CERT ... 58:04

10M ago58:04

58:04

Is it possible to transform carbon emissions into everyday products? Alex is the CEO of CERT Systems, a Canadian climatetech startup that converts CO2 emissions into high-value chemicals. In this episode, Alex shares his journey from the lab bench to raising non-dilutive capital. Topics in this episode 0:00 Intro 1:16 Founding CERT Systems 3:14 Why…

1
Raising Capital in a Controversial Industry | Psychedelics & Mental Health | Building Investor Relationships | Showing Traction Before Regulatory Approval | Imposter Syndrome in LATAM Startups with Victoria ... 55:55

10M ago55:55

55:55

There is a lot of stigma around psychedelics. Vicky is the CEO of EYWA, a biotech startup that produces molecules for mental health treatments. In this episode, we discussed the fundraising process for a startup working with psychedelics and the stigma surrounding the industry. Topics in this episode 0:00 Intro 1:07 Founding EYWA 3:53 Advice for St…

1
Disrupting Drug Discovery: Combining Quantum Electrochemistry and AI | Partnering with Oxford University | Why Second-Time Founders Have a Unique Edge | The Importance of Boldness and Patience with Diego ... 59:23

10M ago59:23

59:23

Investors don’t care how fancy your tech is. Diego is the CEO of Qnity, a pharmatech startup that uses quantum electrochemistry to develop devices for drug discovery and screening. In this episode, we discuss his lessons as a second-time founder and his insights on fundraising in the deeptech space. Topics in this episode 0:00 Intro 1:26 How Was Qn…

1
Picking the VCs You Approach | Protecting Your IP and Building Your Business Model | Creating Therapeutics for Animals Using Black Soldier Flies | Standing Out to Investors While Raising a Seed Round ... 56:05

10M ago56:05

56:05

Why do founders have to be very picky about what VCs they approach? Gerardo Bluske is the Chief Business Officer of ByBug, a biotech startup that creates therapeutics for animals using black soldier flies. In this episode, Gerardo shares his insights about business development and fundraising. Topics in this episode 0:00 Intro 1:27 Who Is Gerardo B…